Abstract
There is a growing interest in the use of volatile anesthetics for inhalational sedation of adult critically ill patients in the ICU. Its safety and efficacy has been demonstrated in various studies and technical equipment such as the anaesthetic conserving device (AnaConDa™; Sedana Medical, Uppsala, Sweden) or the MIRUS™ system (Pall Medical, Dreieich, Germany) have significantly simplified the application of volatile anesthetics in the ICU. However, the personnel’s exposure to waste anesthetic gas during daily work is possibly disadvantageous, because there is still uncertainty about potential health risks. The fact that average threshold limit concentrations for isoflurane, sevoflurane and desflurane either differ significantly between countries or are not even defined at all, leads to raising concerns among ICU staff. In this review, benefits, risks, and technical aspects of inhalational sedation in the ICU are discussed. Further, the potential health effects of occupational long-term low-concentration agent exposure, the staffs’ exposure levels in clinical practice, and strategies to minimize the individual gas exposure are reviewed.
Similar content being viewed by others
References
Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ. 1989;298:1277–80. doi: 10.1136/bmj.298.6683.1277.
Spencer EM, Willatts SM. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med. 1992;18:415–21.
Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med. 2004;32:2241–6. doi: 10.1097/01.CCM.0000145951.76082.77.
Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J, Roustan JP, Chanques G, Jaber S. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med. 2011;37:933–41. doi: 10.1007/s00134-011-2187-3.
Meiser A, Sirtl C, Bellgardt M, Lohmann S, Garthoff A, Kaiser J, Hügler P, Laubenthal HJ. Desflurane compared with propofol for postoperative sedation in the intensive care unit. Br J Anaesth. 2003;90:273–80. doi: 10.1093/bja/aeg059.
Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology. 1993;79(4):795–807. doi: 10.1097/00000542-199310000-00023.
Mazze RI. No evidence of sevoflurane-induced renal injury in volunteers. Anesth Analg. 1998;87(1):230–1. doi: 10.1097/00000539-199807000-00050.
Mazze RI, Callan CM, Galvez ST, Delgado-Herrera L, Mayer DB. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg. 2000;90(3):683–8. doi: 10.1097/00000539-200003000-00032.
Soro M, Gallego L, Silva V, Ballester MT, Lloréns J, Alvariño A, García-Perez ML, Pastor E, Aguilar G, Martí FJ, Carratala A, Belda FJ. Cardioprotective effect of sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double-blind randomized study. Eur J Anaesthesiol. 2012;29:561–9. doi: 10.1097/EJA.0b013e3283560.
Sepac A, Sedlic F, Si-Tayeb K, Lough J, Duncan SA, Bienengraeber M, Park F, Kim J, Bosnjak ZJ. Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology. 2010;113(4):906–16. doi: 10.1097/ALN.0b013e3181eff6b7.
Feng J, Zuo Z. Isoflurane preconditioning increases endothelial cell tolerance to in-vitro simulated ischaemia. J Pharm Pharmacol. 2011;63(1):106–10. doi: 10.1111/j.2042-7158.2010.01198.x.
Arnold JH, Truog RD, Molengraft JA. Tolerance to isoflurane during prolonged administration. Anesthesiology. 1993;78:985–8. doi: 10.1097/00000542-199305000-00026.
Bellgardt M, Bomberg H, Herzog-Niescery J, Dasch B, Vogelsang H, Weber TP, Steinfort C, Uhl W, Wagenpfeil S, Volk T, Meiser A. Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: retrospective analysis. Eur J Anaesthesiol. 2016;33:6–13. doi: 10.1097/EJA.0000000000000252.
Kikuchi C, Dosenovic S, Bienengraeber M. Anaesthetics as cardioprotectants: translatability and mechanism. Br J Pharmacol. 2015;172:2051–61. doi: 10.1111/bph.12981.
Wu L, Zhao H, Wang T, Pac-Soo C, Ma D. Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection. J Anesth. 2014;28:740–58. doi: 10.1007/s00540-014-1805-y.
Kitano H, Kirsch JR, Hurn PD, Murphy SJ. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab. 2007;27:1108–28. doi: 10.1038/sj.jcbfm.9600410.
De Conno E, Steurer MP, Wittlinger M, Zalunardo MP, Weder W, Schneiter D, Schimmer RC, Klaghofer R, Neff TA, Schmid ER, Spahn DR, Z’Graggen BR, Urner M, Beck-Schimmer B. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology. 2009;110:1316–26. doi: 10.1097/ALN.0b013e3181a10731.
Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248:909–18. doi: 10.1097/SLA.0b013e31818f3dda.
Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98:1315–27. doi: 10.1097/00000542-200306000-00004.
Kim M, Park SW, Kim M, D’Agati VD, Lee HAT. Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-beta1 generation. Ann Surg. 2012;255:492–503. doi: 10.1097/SLA.0b013e3182441767.
Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med. 1986;14:832–3. doi: 10.1097/00003246-198609000-00017.
Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61:1254–9. doi: 10.1001/archneur.61.8.1254.
Jerath A, Panckhurst J, Parotto M, Lightfoot N, Wasowicz M, Ferguson ND, Steel A, Beattie WS. Safety and efficacy of volatile anesthetic agents compared with standard intravenous midazolam/propofol sedation in ventilated critical care patients: a meta-analysis and systematic review of prospective trials. Anesth Analg. 2017;124:1190–9. doi: 10.1213/ANE.0000000000001634.
Kong KL, Tyler JE, Willatts SM, Prys-Roberts C. Isoflurane sedation for patients undergoing mechanical ventilation: metabolism to inorganic fluoride and renal effects. Br J Anaesth. 1990;64:159–62. doi: 10.1093/bja/64.2.159.
Spencer EM, Willatts SM, Prys-Roberts C. Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal function. Anesth Analg. 1991;73:731–7.
Njoku D, Laster MJ, Gong DH, Eger EI 2nd, Reed GF, Martin JL. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg. 1997;84:173–8. doi: 10.1213/00000539-199701000-00031.
Gottschalk A, Van Aken H, Zenz M, Standl T. Is anesthesia dangerous? Dtsch Arztebl Int. 2011;108:469–74. doi: 10.3238/arztebl.2011.0469.
Schlack W, Hollmann M, Stunneck J, Thämer V. Effect of halothane on myocardial reoxygenation injury in the isolated rat heart. Br J Anaesth. 1996;76:860–7. doi: 10.1093/bja/76.6.860.
Jerath A, Beattie SW, Chandy T, Karski J, Djaiani G, Rao V, Yau T, Wasowicz M, Perioperative Anesthesia Clinical Trials Group. (2015) Volatile-based short-term sedation in cardiac surgical patients: a prospective randomized controlled trial. Crit Care Med 43:1062–9. doi: 10.1097/CCM.0000000000000938.
Sturesson LW, Malmkvist G, Bodelsson M, Niklason L, Jonson B. Carbon dioxide rebreathing with the anaesthetic conserving device, AnaConDa®. Br J Anaesth. 2012;109:279–83. doi: 10.1093/bja/aes102.
Sturesson LW, Bodelsson M, Jonson B, Malmkvist G. Anaesthetic conserving device AnaConDa: dead space effect and significance for lung protective ventilation. Br J Anaesth. 2014;113:508–14. doi: 10.1093/bja/aeu102.
Fraga M, Rama Marceira P, Rodino S, Aymerich H, Pose P, Belda J. The effect of isoflurane and desflurane on intracranial pressure, cerebral perfusion pressure, and cerebral arteriovenous oxygen content difference in normocapnic patients with supratentorial brain tumors. Anesthesiology. 2003;98:1085–90. doi: 10.1097/00000542-200305000-00010.
Bösel J, Purrucker JC, Nowak F, Renzland J, Schiller P, Pérez EB, Poli S, Brunn B, Hacke W, Steiner T. Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure. Intensive Care Med. 2012;38:1955–64. doi: 10.1007/s00134-012-2708-8.
Purrucker JC, Renzland J, Uhlmann L, Bruckner T, Hacke W, Steiner T, Bösel J. Volatile sedation with sevoflurane in intensive care patients with acute stroke or subarachnoid haemorrhage using AnaConDa®: an observational study. Br J Anaesth. 2015;114:934–43. doi: 10.1093/bja/aev070.
Enlund M, Wiklund L, Lambert H. A new device to reduce the consumption of a halogenated anaesthetic agent. Anaesthesia. 2001;56:429–32. doi: 10.1046/j.1365-2044.2001.01900.x.
Meiser A, Bellgardt M, Belda J, Röhm K, Laubenthal H, Sirtl C. Technical performance and reflection capacity of the anaesthetic conserving device-a bench study with isoflurane and sevoflurane. J Clin Monit Comput. 2009;23:11–9. doi: 10.1007/s10877-008-9158-4.
Bomberg H, Glas M, Groesdonk VH, Bellgardt M, Schwarz J, Volk T, Meiser A. A novel device for target controlled administration and reflection of desflurane—the Mirus™. Anaesthesia. 2014;69:1241–50. doi: 10.1111/anae.12798.
Vaisman AI. Working conditions in the operating room and their effect on the health of anesthetists. Eksp Khir Anesteziol. 1967;12:44–9.
Fink BR, Shepard TH, Blandau RJ. Teratogenic activity of nitrous oxide. Nature. 1967;214:146–8. doi: 10.1038/214146a0.
Occupational disease among operating room personnel: a national study. Report of an Ad Hoc Committee on the Effect of Trace Anesthetics on the Health of Operating Room Personnel, American Society of Anesthesiologists. Anesthesiology. 1974;41:321–40.
Buring JE, Hennekens CH, Mayrent SS. Health experiences of operating room personnel. Anesthesiology. 1985;62:325–30. doi: 10.1097/00000542-198503000-00018.
Bovin JF. Risk of spontaneous abortion in women occupationally exposed to anaesthetic gases: a meta-analysis. Occup Environ Med. 1997;54:541–8. doi: 10.1136/oem.54.8.541.
Knill-Jones RP, Rodrigues LV, Moir DD, Spence AA. Anaesthetic practice and pregnancy. Controlled survey of women anaesthetists in the United Kingdom. Lancet. 1972;1:1326–8.
Cohen EN, Bellville JW, Brown BW Jr. Anesthesia, pregnancy, and miscarriage: a study of operating room nurses and anesthetists. Anesthesiology. 1971;34:343–7. doi: 10.1097/00006254-197204000-00007.
Rosenberg P, Kirves A. Miscarriages among operating theatre staff. Acta Anaesthesiol Scand. 1974;53:37–42. doi: 10.1111/j.1399-6576.1974.tb00780.x.
Spence AA, Knill-Jones RP. Is there a health hazard in anaesthetic practice? Br J Anaesth. 1978;50:713–9. 10.1093/bja/50.7.713.
Spence AA. Environmental pollution by inhalation anaesthetics. Br J Anaesth. 1987;59:96–103. doi: 10.1093/bja/59.1.96.
Friedman JM. Teratogen update: anesthetic agents. Teratology. 1988;37:69–77.
Ferstandig LL. Trace concentrations of anesthetic gases: a critical review of their disease potential. Anesth Analg. 1978;33:430–8. doi: 10.1213/00000539-197805000-00009.
Lauwerys R, Siddons M, Misson CB, Borlee I, Bouckaert A, Lechat MF, De Temmerman P. Anesthetic hazards among Belgian nurses and physicians. Int Arch Occup Environ Health. 1981;48:195–203.
Spence AA. How safe is anesthesia for you and your patient? Data from U.K. Ten years prospective study. Bull N Y State. 1985;12:140–9.
Ericson A, Kallen B. Survey of infants born in 1973 or 1975 to Swedish women working in operating rooms during their pregnancies. Anesth Analg. 1979;58:302–5. doi: 10.1213/00000539-197907000-00008.
Ericson HA, Källén AJ. Hospitalization for miscarriage and delivery outcome among Swedish nurses working in operating rooms, 1973–1978. Anesth Analg. 1985;64:981–8. doi: 10.1213/00000539-198510000-00007.
Sweeney B, Bingham RM, Amos RJ, Petty AC, Cole PV. Toxicity of bone marrow in dentists exposed to nitrous oxide. Br Med J. 1985;291:567–9.
Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ. Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide. N Engl J Med. 1992;327:993–7. doi: 10.1056/NEJM199210013271405.
Rowland AS, Baird DD, Shore DL, Weinberg CR, Savitz DA, Wilcox AJ. Nitrous oxide and spontaneous abortion in female dental assistants. Am J Epidemiol. 1995;41:531–8. doi: 10.1093/oxfordjournals.aje.a117468.
Koblin DD, Waskel L, Watson JE. Nitrous oxide inactivates methyonine synthetase in human liver. Anesth Analg. 1982;61:75–8.
Myles PS, Chan MT, Kaye DM, McIlroy DR, Lau CW, Symons JA, Chen S. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology. 2008;109:657–63. doi: 10.1097/ALN.0b013e31818629db.
Franco G, Fonte R, Ghittori S. Drinking habits and occupational exposure to inhalation anesthetics at low doses. Med Lav. 1993;84:463–72.
Trevisan A, Venturini MB, Carrieri M, Giraldo M, Maccà I, Perini M, Scapellato ML, Virgili A, Bartolucci GB. Biological indices of kidney involvement in personnel exposed to sevoflurane in surgical areas. Am J Ind Med. 2003;44:474–80. doi:10.1002/ajim.10299.
Lucchini R, Belotti L, Cassitto MG, Faillace A, Margonari M, Micheloni G, Scapellato ML, Somenzi V, Spada T, Toffoletto F, Gilioli R. Neurobehavioral functions in operating theatre personnel: a multicenter study. Med Lav. 1997;88:396–405.
Doi M, Ikeda K. Airway irritation produced by volatile anaesthetics during brief inhalation: comparison of halothane, enflurane, isoflurane, and sevoflurane. Can J Anaesth. 1993;40:122–6. doi: 10.1007/BF03011308.
Caraffini S, Ricci F, Assalve D, Lisi P. Isoflurane: an uncommon cause of occupational airborne contact dermatitis. Contact Dermat. 1998;38:286. doi: 10.1111/j.1600-0536.1998.tb05749.x.
Finch TM, Muncaster A, Prais L, Foulds IA. Occupational airborne allergic contact dermatitis from isoflurane vapour. Contact Dermat. 2000;42:46.
Johnson JA, Buchan RM, Reif JS. Effect of waste anesthetic gas and vapor exposure on reproductive outcome in veterinary personnel. Am Ind Hyg Assoc J. 1987;48:62–6. doi: 10.1080/15298668791384373.
Baxter. Highlights of prescribing information. Suprane (desflurane, USP) volatile liquid inhalation. Deerfield: Baxter Healthcare Corporation;2010.
Kennedy GL, Smith SH, Keplimger ML, Calandra JC. Reproductive and teratologic studies with isoflurane. Drug Chem Toxicol. 1977;1:75–88. doi: 10.3109/01480547709034428.
Kanazawa M, Kinefuchi Y, Suzuki T, Fukuyama H, Takiguchi M. The use of sevoflurane anesthesia during early pregnancy. Tokai J Exp Clin Med. 1999;24:53–5.
Guirguis SS, Pelmear PL, Roy ML, Wong L. Health effects associated with exposure to anaesthetic gases in Ontario hospital personnel. Br J Ind Med. 1990;47:490–7. doi: 10.1136/oem.47.7.490.
Mazze RI. Fertility, reproduction, and postnatal survival in mice chronically exposed to isoflurane. Anesthesiology. 1985;63:663–7. doi: 10.1097/00000542-198512000-00017.
Karpiński TM, Kostrzewska-Poczekaj M, Stachecki I, Mikstacki A, Szyfter K. Genotoxicity of the volatile anaesthetic desflurane in human lymphocytes in vitro, established by comet assay. J Appl Genet. 2005;46:319–24.
Şardaş S, Aygün N, Gamli M, Ünal Y, Berk N, Karakaya AE. Use of alkaline COMET assay (single cell gel electrophoresis technique) to detect DNA damages in lymphocytes of operating room personnel occupationally exposed to anaesthetic gases. Mutat Res. 1998;418:93–100.
Hoerauf K, Lierz M, Wiesner G, Schroegendorfer K, Lierz P, Spacek A, Brunnberg L, Nüsse M. Genetic damage in operating room personnel exposed to isoflurane and nitrous oxide. Occup Environ Med. 1999;56:433–7. doi: 10.1136/oem.56.7.433.
Hoerauf K, Wiesner G, Schroegendorfer KF, Jobst BP, Spacek A, Harth M, Sator-Katzenschlager S, Rüdiger HW. Waste anaesthetic gases induce sister chromatid exchanges in lymphocytes of operating room personnel. Br J Anaesth. 1999;82:764–6. doi: 10.1093/bja/82.5.764.
Trudnowski RJ, Mehta MP, Rucinski M. Evaluation of the mutagenic potential of enflurane und isoflurane by sister chromatid exchange. J Med. 1987;18:55–60.
Karabiyik L, Şardaş S, Polat U, Kocabaş NA, Karakaya AE. Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay. Mutat Res. 2001;492:99–107. doi: 10.1016/S1383-5718(01)00159-0.
Szyfter K, Szulc R, Mikstacki A, Stachecki I, Rydzanicz M, Jałoszyński P. Genotoxicity of inhalation anaesthetics: DNA lesions generated by sevoflurane in vitro and in vivo. J Appl Genet. 2004;45:369–74.
Lüleci N, Sakarya M, Topçu I, Lüleci E, Erinçler T, Solak M. Effects of sevoflurane on cell division and levels of sister chromatid exchange. Anaesthesiol Intensivmed Notfallmed Schmerzther. 2005;40:213–6.
Herzog-Niescery J, Botteck NM, Vogelsang H, Gude P, Bartz H, Weber TP, Seipp HM. Occupational chronic sevoflurane exposure in the everyday reality of the anesthesia workplace. Anesth Analg. 2015;121:1519–28. doi: 10.1213/ANE.0000000000001015.
Accorsi A, Barbieri A, Raffi GB, Violante FS. Biomonitoring of exposure to nitrous oxide, sevoflurane, isoflurane and halothane by automated GC/MS headspace urinalysis. Int Arch Occup Environ Health. 2001;74:541–8. doi: 10.1007/s004200100263.
Imbriani M, Ghittori S, Pezzagno G. The biological monitoring of inhalation anaesthetics. G Ital Med Lav Ergon. 1998;20:44–9.
Coleman MA, Coles S, Lytle T, Bennetts FE. Prevention of atmospheric contamination during isoflurane sedation. Clin Intensive Care. 1994;5:217–20.
Hoerauf K, Koller C, Vescia F, Metz C, Hobbhahn J. Exposure of intensive care personnel to isoflurane in long-term sedation. Anasthesiol Intensivmed Notfallmed Schmerzther. 1995;30:483–7.
Byhahn C, Lischke V, Westphal K. Arbeitsplatzbelastung im Krankenhaus mit Lachgas und den neuen Inhalationsanästhetika Desfluran und Sevofluran. Dtsch med Wochenschr. 1999;124:137–41.
Djafari Marbini H, Palayiwa E, Chantler J. Active gas scavenging is unnecessary when using the AnaConDa volatile agent delivery system. J Intensive Care Soc. 2009;1:26–8. doi: 10.1177/175114370901000108.
Pickworth T, Jerath A, DeVine R, Kherani N, Wąsowicz M. The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: a technical report. Can J Anaesth. 2013;60:38–43. doi: 10.1007/s12630-012-9814-5.
Wong K, Wasowicz M, Grewal D, Fowler T, Ng M, Ferguson ND, Steel A, Jerath. Efficacy of a simple scavenging system for long-term critical care sedation using volatile agent-based anesthesia. Can J Anaesth. 2016;63(5):630–2. doi: 10.1007/s12630-015-0562-1.
González-Rodríguez R, Muñoz Martínez A, Galan Serrano J, Moral García MV. Health worker exposure risk during inhalation sedation with sevoflurane using the (AnaConDa®) anaesthetic conserving device. Rev Esp Anestesiol Reanim. 2014;61:133–9.
American Institute of Architects. Guidelines for construction and equipment of hospitals and medical facilities. Washington, DC: American Institute of Architects; 1992.
Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol. 2005;19:523–38.
Soukup J, Schärff K, Kubosch K, Pohl C, Bomplitz M, Kompardt J. State of the art: sedation concepts with volatile anesthetics in critically Ill patients. J Crit Care. 2009;24(4):535–44. doi: 10.1016/j.jcrc.2009.01.003.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Herzog-Niescery has received a speaker honorarium from Pall Medical, Dreieich, Germany. Seipp and Weber declares that they have no conflict of interest. Bellgardt has received a speaker honorarium from Pall Medical, Dreieich, Germany.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Herzog-Niescery, J., Seipp, HM., Weber, T.P. et al. Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review. J Clin Monit Comput 32, 667–675 (2018). https://doi.org/10.1007/s10877-017-0055-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10877-017-0055-6